Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 1066 AL 1080

Genetic Markers of Alzheimer's Disease

Nikolac Perkovic M, Pivac N.

Adv Exp Med Biol. 2019;1192:27-52. doi: 10.1007/978-981-32-9721-0_3.

Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer's Disease

Olasehinde TA, Olaniran AO, Okoh AI.

Mar Drugs. 2019 Oct 25;17(11):609. doi: 10.3390/md17110609.

Neutral Endopeptidase (Neprilysin) in Therapy and Diagnostics: Yin and Yang

Feygina EE, Katrukha AG, Semenov AG.

Biochemistry (Mosc). 2019 Nov;84(11):1346-1358. doi: 10.1134/S0006297919110105.

Functional Connectivity in Neurodegenerative Disorders: Alzheimer's Disease and Frontotemporal Dementia

Jalilianhasanpour R, Beheshtian E, Sherbaf G, Sahraian S, Sair HI.

Top Magn Reson Imaging. 2019 Dec;28(6):317-324. doi: 10.1097/RMR.0000000000000223.

Oxidative Damage of DNA as Early Marker of Alzheimer's Disease

Peña-Bautista C, Tirle T, López-Nogueroles M, Vento M, Baquero M, Cháfer-Pericás C.

Int J Mol Sci. 2019 Dec 5;20(24):6136. doi: 10.3390/ijms20246136.

A cerebrospinal fluid biosignature for the diagnosis of Alzheimer's disease

Barichello T, Giridharan VV, Dal-Pizzol F.

Braz J Psychiatry. 2019 Nov-Dec;41(6):467-468. doi: 10.1590/1516-4446-2019-0629.

Dementia is not synonymous with Alzheimer's disease

Jack CR Jr, Holtzman DM, Sperling R.

Sci Transl Med. 2019 Dec 11;11(522):eaav0511. doi: 10.1126/scitranslmed.aav0511.

Cerebrospinal fluid and blood Aβ levels in Down syndrome patients with and without dementia: a meta-analysis study

Du Y, Chen L, Jiao Y, Cheng Y.

Aging (Albany NY). 2019 Dec 20;11(24):12202-12212. doi: 10.18632/aging.102560. Epub 2019 Dec 20.

Biomarkers for Alzheimer's disease. Where we stand and where we are headed

Chrem Mendez P, Surace E, Bérgamo Y, Calandri I, Vázquez S, Sevlever G, Allegri RF.

Medicina (B Aires). 2019;79(Spec 6/1):546-551.

CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia

Abu-Rumeileh S, Steinacker P, Polischi B, Mammana A, Bartoletti-Stella A, Oeckl P, Baiardi S, Zenesini C, Huss A, Cortelli P, Capellari S, Otto M, Parchi P.

Alzheimers Res Ther. 2019 Dec 31;12(1):2. doi: 10.1186/s13195-019-0562-4.

The relationship between cholesterol level and Alzheimer's disease-associated APP proteolysis/Aβ metabolism

Wang C, Shou Y, Pan J, Du Y, Liu C, Wang H.

Nutr Neurosci. 2019 Jul;22(7):453-463. doi: 10.1080/1028415X.2017.1416942. Epub 2018 Jan 11.

The Evolving Dialogue of Microglia and Neurons in Alzheimer's Disease: Microglia as Necessary Transducers of Pathology

Simon E, Obst J, Gomez-Nicola D.

Neuroscience. 2019 May 1;405:24-34. doi: 10.1016/j.neuroscience.2018.01.059. Epub 2018 Feb 8.

Strategic value-directed learning and memory in Alzheimer's disease and behavioural-variant frontotemporal dementia

Wong S, Irish M, Savage G, Hodges JR, Piguet O, Hornberger M.

J Neuropsychol. 2019 Jun;13(2):328-353. doi: 10.1111/jnp.12152. Epub 2018 Feb 12.

Dysfunctional γ-Secretase in Familial Alzheimer's Disease

Wolfe MS.

Neurochem Res. 2019 Jan;44(1):5-11. doi: 10.1007/s11064-018-2511-1. Epub 2018 Apr 4.

Can Animal Models Inform on the Relationship between Depression and Alzheimer Disease?

Nyarko JNK, Quartey MO, Baker GB, Mousseau DD.

Can J Psychiatry. 2019 Jan;64(1):18-29. doi: 10.1177/0706743718772514. Epub 2018 Apr 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias